Anlon Healthcare has completed the acquisition of 67.48% equity shareholding of Apiqo Organics on January 9, 2026. Consequent to this acquisition, Apiqo Organics has become a subsidiary of the company. The acquisition of the Apiqo Organics will significantly enhances the company’s vertical integration, secures critical supply of high-quality intermediates, increases additional 700 to 800 MT annual manufacturing capacity for advanced pharmaceutical intermediates, and strengthens the ability of the company to deliver reliable, cost-effective solutions to its global pharmaceutical partners.
Earlier, the company had entered into a Share Purchase Agreement (SPA) with Apiqo Organics (formerly known as M/s Apple Life Science, a partnership firm) for the same.
Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: